A prospective, randomized, double blind, placebo-controlled, multicenter, Phase 2b study of OTO-104 given as a single intratympanic injection in subjects with unilateral Menieres disease (104-201102)

Awarded By

Contributors

Start/End

  • April 1, 2014 - December 16, 2015